Cargando…

A Retrospective Study of Early vs Delayed Home Dose Basal Insulin in the Acute Management of Diabetic Ketoacidosis

BACKGROUND: Insulin via continuous intravenous infusion (ICII) is a standard of care for treating patients with diabetic ketoacidosis (DKA). Once DKA is resolved, ICII is transitioned to subcutaneous therapy. However, recent guidelines recommend continuation of home dose subcutaneous basal insulin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rappaport, Stephen H, Endicott, Jeffrey A, Gilbert, Matthew P, Farkas, Joshua D, Clouser, Ryan D, McMillian, Wesley D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500796/ https://www.ncbi.nlm.nih.gov/pubmed/31069278 http://dx.doi.org/10.1210/js.2018-00400

Ejemplares similares

Compliance with the Eastern Association for the Surgery of Trauma guidelines for prophylactic antibiotics after open extremity fracture
por: Barton, Cassie A, et al.
Publicado: (2012)

Relationships of Educational Attainment and Household Food Insecurity with Obesity: Findings from the 2007–2016 National Health and Nutrition Examination Survey
por: McMillian, M. Monique, et al.
Publicado: (2021)

Considerations and Recommendations for Care of Black Pregnant Patients During COVID-19
por: McMillian-Bohler, Jacquelyn, et al.
Publicado: (2022)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?
por: Kitabchi, Abbas E., et al.
Publicado: (2008)

Development of Trigger Films to Explore Nursing Students’ Attitudes Toward Patients with Obesity
por: Molloy, Margory A., et al.
Publicado: (2023)

Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis
por: Malerba, Eleonora, et al.
Publicado: (2020)

Hospital Discharge Data for Guillain-Barré Syndrome and Influenza A (H1N1) Vaccine Adverse Events
por: Jones, Timothy F., et al.
Publicado: (2010)

ABC gene-ranking for prediction of drug-induced cholestasis in rats
por: Cherkas, Yauheniya, et al.
Publicado: (2016)

Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats
por: Anderson, Jodie D., et al.
Publicado: (2019)

Research Note: Comparison of two methods to measure broiler tibia morphology
por: Magnaterra, A., et al.
Publicado: (2022)

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
por: Knierman, Michael D., et al.
Publicado: (2020)

Higher-Than-Conventional Subcutaneous Regular Insulin Doses Following Diabetic Ketoacidosis in Children and Adolescents
por: Bağ, Özlem, et al.
Publicado: (2017)

A retrospective cohort study for the treatment of Asian diabetic ketoacidosis: optimizing initial doses of insulin
por: Hishida, Yoshiaki, et al.
Publicado: (2021)

Effect of Bolus Insulin Administration Followed by a Continuous Insulin Infusion on Diabetic Ketoacidosis Management
por: Brown, Hannah D., et al.
Publicado: (2018)

Management of Diabetic Ketoacidosis in Severe Insulin Resistance
por: Robinson, Cemre, et al.
Publicado: (2016)

Efficacy and Safety of Low Dose Insulin Infusion against Standard Dose Insulin Infusion in Children with Diabetic Ketoacidosis- An Open Labelled Randomized Controlled Trial
por: Saikia, Diganta, et al.
Publicado: (2022)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
por: Orchard, Trevor J., et al.
Publicado: (2017)

Extracellular heat shock protein 70 inhibits tumour necrosis factor-α induced proinflammatory mediator production in fibroblast-like synoviocytes
por: Luo, Xinjing, et al.
Publicado: (2008)

Evaluation of REDCap to Supplement Foodborne Disease Surveillance Systems
por: Golwalkar, Mugdha, et al.
Publicado: (2019)

Interventions Using Wearable Physical Activity Trackers Among Adults With Cardiometabolic Conditions: A Systematic Review and Meta-analysis
por: Hodkinson, Alexander, et al.
Publicado: (2021)

Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis: A Subgroup Analysis of Cluster Randomized Clinical Trials
por: Self, Wesley H., et al.
Publicado: (2020)

Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations
por: Orozco‐Beltran, D., et al.
Publicado: (2016)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
por: Nasrallah, Sami N., et al.
Publicado: (2012)

Isoproterenol Induced Insulin Resistance Leading to Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
por: Hoff, Ryan, et al.
Publicado: (2018)

Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
por: Kinney, Justin, et al.
Publicado: (2021)

Elasomeran/insulin: Diabetic ketoacidosis, insulin resistance and lack of efficacy: case report
Publicado: (2022)

Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
por: Boucher-Berry, Claudia, et al.
Publicado: (2016)

ODP231 Outcomes of Weight-based vs. Constant-based Insulin Infusion for Treatment of Diabetic Ketoacidosis in Non-ICU Patients
por: Alrifai, Nada, et al.
Publicado: (2022)

The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Insulin Infusion Dosing in Pediatric Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Forestell, Ben, et al.
Publicado: (2023)

Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
por: Mocarski, Michelle, et al.
Publicado: (2018)

Hepatic Bioactivation of Skin-Sensitizing Drugs to Immunogenic Reactive Metabolites
por: Chong, Lor Huai, et al.
Publicado: (2019)

Concentrated insulins: the new basal insulins
por: Lamos, Elizabeth M, et al.
Publicado: (2016)

Severe allergic reaction to human insulin in the patient with diabetic ketoacidosis
por: Oray, Nese Colak, et al.
Publicado: (2017)

Searching for the Culprit: When Diabetic Ketoacidosis Presents With Insulin Autoantibodies
por: Garcia-Avila, Scarlette, et al.
Publicado: (2020)

Glargine versus regular insulin protocol in feline diabetic ketoacidosis
por: Zeugswetter, Florian K., et al.
Publicado: (2021)

Insulin Requirements for Patients With COVID-19 Presenting With Diabetic Ketoacidosis
por: Nagy, Ahmed, et al.
Publicado: (2023)

Diabetic Ketoacidosis and Profound Insulin Resistance From Brentuximab Vedotin
por: Thakkar, Keval, et al.
Publicado: (2023)

Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin
por: Goldman, Jennifer D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o4mnh1apqjikceng9mcoqj44cg